Browse > Article
http://dx.doi.org/10.5352/JLS.2018.28.9.1076

Evaluating the Immunological Adjuvant Activities of Carrageenan and Degraded Carrageenan  

Park, Ji-Hun (Department of Microbiology, College of Medicine, Dankook University)
Choi, Tae-Saeng (Department of Microbiology, College of Medicine, Dankook University)
Publication Information
Journal of Life Science / v.28, no.9, 2018 , pp. 1076-1080 More about this Journal
Abstract
Carrageenan (CGN) has been used as a safe food additive for several decades. CGN has also been widely used to induce inflammation in various animal models. Likewise, degraded CGN (dCGN), which is produced by subjecting CGN to acid hydrolysis, also induces inflammation and does so more effectively than CGN. One of the most important characteristics of an immunological adjuvant is its ability to activate innate immunity. The immune-adjuvant effects of CGN and dCGN have not yet been studied in detail. The purpose of this study was to evaluate the immunological adjuvant activities of both CGN and dCGN, which was done by comparing the levels of an ovalbumin (OVA)-specific antibody after treatment with OVA in the absence or presence of CGN or dCGN in plasma from immunized mice. CGN and dCGN showed similar levels of adjuvant activity, as evidenced by increased antibody titer. Specifically, both CGN and dCGN significantly increased the levels of OVA-specific IgG, IgG1, and IgG2a antibodies in the plasma as compared with OVA alone (the control). However, compared to the positive control (Freund's adjuvant), both CGN and dCGN caused greater increases in IgG1 than in IgG2a. These results suggest that CGN and dCGN have similar adjuvant activities and produce more IgG1 antibodies than IgG2a.
Keywords
Antibody; carrageenan (CGN); degraded carrageenan (dCGN); immunological adjuvant; $TNF-{\alpha}$;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Schijns, V. E. and Tangeras, A. 2005. Vaccine adjuvant technology: from theoretical mechanisms to practical approaches. Dev. Biol. (Basel) 121, 127-134.
2 Tobacman, J. K. 2001. Review of harmful gastrointestinal effects of carrageenan in animal experiments. Environ. Health Perspect. 109, 983-994.   DOI
3 Zia, K. M., Tabasum, S., Nasif, M., Sultan, N., Aslam, N., Noreen, A. and Zuber, M. 2017. A review on synthesis, properties and applications of natural polymer based carrageenan blends and composites. Int. J. Biol. Macromol. 96, 282-301.   DOI
4 Campo, V. L., Kawano, D. F., Silva, D. B. and Carvalho, D. I. 2009. Carrageenans: Biological properties, chemical modifications and structural analysis- A review. Carbohydr. Polym. 77, 167-180.   DOI
5 Anver, M. R. and Cohen, J. 1976. Animal model of human disease. Ulcerative colitis, Animal model: ulcerative colitis induced in guinea pigs with degraded carrageenan. Am. J. Pathol. 84, 431-434.
6 Ariffin, S. H., Yeen, W. W., Abidin, I. Z., Abdul Wahab, R. M., Ariffin, Z. Z. and Senafi, S. 2014. Cytotoxicity effect of degraded and undegraded Kappa and iota carrageenan in human intestine and liver cell lines. BMC Complement Altern. Med. 14, 508-523.   DOI
7 Ashi, K. W., Inagaki, T., Fujimoto, Y. and Fukuda, Y. 1978. Induction by degraded carrageenan of colorectal tumors in rats. Cancer Lett. 4, 171-176.   DOI
8 Barth, C. R., Funchal, G. A., Luft, C., de Oliveira, J. R., Porto, B. N. and Donadio, M. V. 2016. Carrageenan-induced inflammation promotes ROS generation and neutrophil extracellular trap formation in a mouse model of peritonitis. Eur. J. Immunol. 46, 964-970.   DOI
9 Brunner, R., Jensen-Jarolim, E. and Pali-Scholl, I. 2010. The ABC of clinical and experimental adjuvants-a brief overview. Immunol. Lett. 128, 29-35.   DOI
10 Chen, H., Wang, F., Mao, H. and Yan, X. 2014. Degraded $\lambda$-carrageenan activates NF-kB and AP-1 pathways in macrophages and enhances LPS-induced TNF-${\alpha}$ secretion through AP-1. Biochim. Biophys. Acta. 1840, 2162-2170.   DOI
11 Jiao, G., Yu, G., Zhang, J. and Ewart, H. S. 2011. Chemical structures and bioactivities of sulfated polysaccharides from marine algae. Mar. Drugs 9, 196-223.   DOI
12 Ekstrom, L. G. 1985. Molecular weight distribution and the behavior of kappa-carrageenan on hydrolysis. Carbohydr. Res. 135. 283-289.   DOI
13 Ekstrom, L. G., Kuivinen, J. and Johansson, G. 1983. Molecular weight distribution and hydrolysis behavior of carrageenans. Carbohydr. Res. 116, 89-94..   DOI
14 Fath, R. B Jr., Deschner, E. E., Winawer, S. J. and Dworkin, B. M. 1984. Degraded carrageenan-induced colitis in CF1 mice. Digestion 29, 197-203.   DOI
15 Fischetti, L., Zhong, Z., Pinder, C. L., Tregoning, J. S. and Shattock, R. J. 2017. The synergistic effects of combining TLR ligand based adjuvants on the cytokine response are dependent upon p38/JNK signaling. Cytokine 99, 287-296.   DOI
16 HogenEsch, H. 2002. Mechanisms of stimulation of the im mune response by aluminum adjuvants. Vaccine 20 Suppl 3, S34-39.   DOI
17 Masson, C. R. and Caines, G. W. 1954. Viscosity and molecular weight of degraded carrageenan. Can. J. Chem. 32, 51-59.   DOI
18 Morris, C. J. 2003. Carrageenan-induced paw edema in the rat and mouse. Methods Mol. Biol. 225, 115-121.
19 Oohashi, Y., Ishioka, T., Wakabayashi, K. and Kuwabara, N. 1981. A study on carcinogenesis induced by degraded carrageenan arising from squamous metaplasia of the rat colorectum. Cancer Lett. 14, 267-272.   DOI
20 Duarte, D. B., Vasko, M. R. and Fehrenbacher, J. C. 2016. Models of inflammation: Carrageenan Air Pouch. Curr. Protoc. Pharmacol. 72, 561-569.
21 Prajapati, V. D., Maheriya, P. M., Jani, G. K. and Solanki, H. K. 2014. Carrageenan: a natural seaweed polysaccharide and its applications. Carbohydr. Polym. 105, 97-112.   DOI